WHO Recommendation AstraZeneca/SKBio - COVID-19 Vaccine (ChAdOx1-S [recombinant])


Product Overview

Vaccine type: COVID-19 Vaccine (ChAdOx1-S ([recombinant])    
Commercial name: Vaxzevria    
Manufacturer: AstraZeneca/SK Bioscience Co. Ltd    
Country: Republic of Korea    
URL: https://www.astrazeneca.com
Responsible NRA: Ministry of Food and Drug Safety    
Country: Republic of Korea    

WHO Recommendation

Effective date: 15 February 2021    

Product Description

Pharmaceutical form: Solution for injection    
Presentation: Vial    
Number of doses: 10 doses    
Diluent: Not applicable    
Route of administration Intramuscular    
Shelf-life: 6 months at storage temperature: 2°C to 8°C           
Vaccine vial monitor: None    
Secondary packaging: Carton holds 10 vaccine vials (100 doses)
Dimensions: 13.2 x 5.7 x 5.0 cm
Tertiary packaging: 24 secondary packaged cartons containing 10 vials per carton
(240 vials /2400 doses): Dimensions: 24.8 x 28.8 x 18.0 cm
Cold chain volume: 3.76 cm3 (in secondary packaging)  
Preservative: Not applicable with concentration: Not applicable
Handling of opened multidose-vials: WHO recommends that opened vials of this vaccine should be discarded 6 hours after opening or at the end of the immunization session, whichever comes first.